Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-transplant Events

Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source

Bone Marrow Transplantation volume 49, pages 102–109 (2014)Cite this article

Subjects

Abstract

Donor cell-derived leukemia (DCL) is a rare complication of SCT. Here, we present a case of DCL following cord blood transplantation (CBT) and review the clinical features of previously reported DCL. To our knowledge, this is the first report comparing clinical characteristics of DCL from the standpoint of the transplant source, with umbilical cord blood and BM. AML and myelodysplastic syndrome (MDS) were recognized more frequently in DCL after CBT, whereas the incidence of AML and ALL was similar after BMT. The median duration between the occurrence of DCL following CBT and BMT was 14.5 and 36 months, respectively. DCL occurred in a significantly shorter period after CBT than after BMT. Abnormal karyotypes involving chromosome 7 were observed in 52.4% of CBT recipients and 17.3% of BMT recipients; this was a statistically significant difference. Particularly, the frequency of monosomy 7 was significantly higher in DCL after CBT than after BMT. The types of abnormal karyotypes in DCL following BMT were similar to those characteristically observed in adult de novo AML and MDS. DCL patients generally have a poor prognosis in both groups. SCT is the best treatment for curing DCL. DCL appears to have different clinical features according to the transplant source.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Fialkow PJ, Thomas ED, Bryant JL, Neiman PE . Leukemic transformation of engrafted human marrow cells in vivo. Lancet 1971; 1: 251–255.

    Article  CAS  PubMed  Google Scholar 

  2. Wiseman DH . Donor cell leukemia: a review. Biol Blood Marrow Transplant 2011; 17: 771–789.

    Article  PubMed  Google Scholar 

  3. Matsunaga T, Murase K, Yoshida M, Fujimi A, Iyama S, Kuribayashi K et al. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. Am J Hematol 2005; 79: 294–298.

    Article  PubMed  Google Scholar 

  4. Fraser CJ, Hirsch BA, Dayton V, Creer MH, Neglia JP, Wagner JE et al. First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood 2005; 106: 4377–4380.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cutler C, Ballen K . Improving outcomes in umbilical cord blood transplantation: State of the art. Blood Rev 2012; 26: 241–246.

    Article  PubMed  Google Scholar 

  6. Ando T, Yujiri T, Mitani N, Takeuchi H, Nomiyama J, Suguchi M et al. Donor cell-derived myeloid leukemia after unrelated umbilical cord blood transplantation. Leukemia 2006; 20: 744–745.

    Article  CAS  PubMed  Google Scholar 

  7. Sevilla J, Querol S, Molines A, Vicent GM, Balas A, Carrio A et al. Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol 2006; 77: 259–263.

    Article  PubMed  Google Scholar 

  8. Mitsui H, Nakazawa T, Tanimura A, Karasuno T, Hiraoka A . Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol 2007; 86: 192–195.

    Article  PubMed  Google Scholar 

  9. Inoue TN, Kodo H, Takahashi TA, Mugishima H, Tojo A, Asano S . Four cases of donor cell-derived AML following unrelated cord blood transplantation for adult patients: experiences of the Tokyo Cord Blood Bank. Cytotherapy 2007; 9: 727–728.

    Article  Google Scholar 

  10. Iwato K, Katayama Y, Nagoshi H, Ota I, Yuasa H, Asaoku H et al. Donor cell derived AML after cord blood transplantation in a patient with refractory ALL. Jpn J Clin Hematol 2007; 48: 1168 (abstr).

    Google Scholar 

  11. Hamaki T, Kajiwara K, Kami M, Murashige H, Funaki M, Harima A et al. Donor cell-derived acute monoblastic leukemia involving MLL gene translocation in an adult patient who received umbilical cord blood transplantation. Bone Marrow Transplant 2008; 41: 91–92.

    Article  CAS  PubMed  Google Scholar 

  12. Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kato S et al. Donor cell-derived myelodysplastic syndrome after cord blood transplantation. Bone Marrow Transplant 2009; 43: 429–431.

    Article  CAS  PubMed  Google Scholar 

  13. Ohnaka T, Yonezawa S, Imada K . A case of donor cell leukemia following cord blood transplantation for recurrent follicular lymphoma underwent second cord blood transplantation. The 30th Annual Meeting of the Jpn J Hematopoietic Cell Transplant 2009, 186 (abstr).

  14. Castleton AZ, Brazma D, Reeves JH, Chanalaris A, Glanville J, Nizetic D et al. Genome gains at chromosome 21q21/22 segment leads to co-amplification of Down syndrome critical regions and known oncogenes in a case of donor cell-derived acute myeloid leukemia following allogeneic sex mismatched umbilical cord blood transplantation for chronic myeloid leukemia. Br J Haematol 2010; 151: 285–288.

    Article  PubMed  Google Scholar 

  15. Crow J, Youens K, Michalowski S, Perrine G, Emhart C, Johnson F et al. Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis. J Mol Diag 2010; 12: 530–537.

    Article  CAS  Google Scholar 

  16. Shono Y, Kanaya MK, Shiratori S, Sugita J, Fujimoto K, Kondo T et al. Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making. Int J Hematol 2011; 93: 563–565.

    Article  PubMed  Google Scholar 

  17. Yoshida M, Takemura R, Kosugi M, Shiratori S, Shono Y, Takeda M et al. Donor cell leukemia after umbilical cord blood transplantation. Jpn J Clin Hematol 2011; 52: 1241 (abstr).

    Google Scholar 

  18. Gustafsson B, Moell J, LeBlanc K, Barbany G, Söderhäll S, Winiarski J . Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia. Pediatr Transplant 2011; 16: 241–245.

    Article  Google Scholar 

  19. Yamazaki R, Nakasone H, Wada H, Sakamoto K, Ashizawa M, Sato M et al. Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation. Exp Hematol 2011; 39: 1119–1123.

    Article  PubMed  Google Scholar 

  20. Wang E, Hutchinson CB, Huang Q, Lu CM, Crow J, Wang FF et al. Donor cell-derived leukamias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients. A clinicopathologic study of 10 cases and a comprehensive review of the literature. Am J Clin Pathol 2011; 135: 525–540.

    Article  PubMed  Google Scholar 

  21. Cotter R, Najfeld V, Isola L, Toro GD, Roman E, Peterson B et al. An unusual case of donor-derived myelodysplastic syndrome following double-unit umbilical cord blood transplantation in acute lymphoblastic leukemia. Am J Hematol 2012; 9: 931–933.

    Article  Google Scholar 

  22. Chonabayashi K, Kondo T, Yamamoto K, Tanaka Y, Nagai Y, Hishizawa M et al. Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor dell-derived AML harboring a FLT3-ITD and an NPM 1 mutation. Bone Marrow Transplant 2012; 47: 1252–1253.

    Article  CAS  PubMed  Google Scholar 

  23. Sugimori C, Yoshida A, Munemoto S, Zaimoku Y, Sawazaki A, Yamaguchi M et al. Donor-type myelodysplastic syndrome after cord blood transplant in a patient with aplastic anemia. Jpn J Clin Hematol 2012; 53: 1277 (abstr).

    Google Scholar 

  24. Macias GR, Laperche CM, Gayoso J, Noriega V, Serrano D, Balsalobre P et al. Mutation of the NPM 1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia. Human Pathol 2013; 44: 1696–1699.

    Article  Google Scholar 

  25. Hamahata K, Kotani S, Oka S, Ukyo N, Watanabe N, Nogawa M . Development of donor cell leukemia mimicking hematogones after unrelated cord blood transplantation for relapsed acute lymphoblastic leukemia. Jpn J Clin Hematol 2013; 54: 473–477.

    Google Scholar 

  26. Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Johnson FL et al. Leukemic transformation of engrafted human marrow cells in vivo. Lancet 1972; 1: 1310–1313.

    Article  CAS  PubMed  Google Scholar 

  27. Elfenbein GJ, Brogaonkar DS, Bias WB, Burns WH, Saral R, Sensenbrenner LL et al. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood 1978; 52: 627–636.

    CAS  PubMed  Google Scholar 

  28. Newburger PE, Latt SA, Pesando JM, Gustashaw K, Powers M, Chaganti RSK et al. Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. N Eng J Med 1981; 304: 712–714.

    Article  CAS  Google Scholar 

  29. Smith JL, Heerema NA, Provisor AJ . Leukaemic transformation of engrafted bone marrow cells. Br J Haematol 1985; 60: 415–422.

    Article  CAS  PubMed  Google Scholar 

  30. Witherspoon RP, Schubach W, Neiman P, Martin P, Thomas ED . Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood 1985; 65: 1172–1174.

    CAS  PubMed  Google Scholar 

  31. Palka G, Di Bartolomeo P, Iacone A, Di Girolamo G, Betti S, Calabrese G . Cytogenetics and bone marrow transplantation. Cancer Genet Cytogenet 1986; 21: 147–157.

    Article  CAS  PubMed  Google Scholar 

  32. Feig SA, Dreazen O, Simon M, Wiley F, Schreck R, Gale RP . B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplant 1988; 3: 331–337.

    CAS  PubMed  Google Scholar 

  33. Cullis JO, Marks DI, Schwarer AP, Barrett AJ, Hows JM, Swirsky DM et al. Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases. Br J Haematol 1992; 81: 378–382.

    Article  CAS  PubMed  Google Scholar 

  34. Cransac M, Boiron J-M, Merel P, Cony-Makhoul P, Marit G, Bernard P et al. Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation 1993; 56: 120–123.

    Article  CAS  PubMed  Google Scholar 

  35. Fyles GM, Minden MD, Meharchand JM, Lipton JH, Atkins HL, Tejpar I et al. Donor cell derived acute myelogenous leukemia developing post allogeneic bone marrow transplant for a patient with chronic myelogenous leukemia. J Cell Biochem 1994; 18: 63 (abstr).

    Google Scholar 

  36. Cooly LD, Sears DA, Udden MM, Harrison WR, Baker KR . Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol 2000; 63: 46–53.

    Article  Google Scholar 

  37. Katz F, Reeves BR, Alexander S, Kearney L, Chessells J . Leukaemia arising in donor cells following allogeneic bone marrow transplantation for β thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis. Br J Haematol 1993; 85: 326–331.

    Article  CAS  PubMed  Google Scholar 

  38. Marmont AM, Frassoni F, Bacigalupo A, Podesta M, Piaggio G, Van Lint MT et al. Recurrence of Ph1-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. N Eng J Med 1984; 310: 903–906.

    Article  CAS  Google Scholar 

  39. Schmitz N, Johannson W, Schmidt G, Von der Helm K, Löffler H . Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood 1987; 70: 1099–1104.

    CAS  PubMed  Google Scholar 

  40. Mouratidou M, Sotiropoulos D, Deremitzaki K, Spathas DH, Hoffbrand AV, Prentice HG et al. Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. Bone Marrow Transplant 1993; 12: 77–80.

    CAS  PubMed  Google Scholar 

  41. Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S et al. Development of leukemia in donor cells after allogeneic stem cell transplantation-a survey of the European Group for Blood and Marrow Transplantation(EBMT). Haematologica 2005; 90: 969–975.

    PubMed  Google Scholar 

  42. Browne PV, Lawler M, Humphries P, McCann SR . Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Eng J Med 1991; 325: 710–713.

    Article  CAS  Google Scholar 

  43. Abeliovich D, Yehuda O, Nagler A, Lerer I, Ben-Neriah S, Amar A et al. Predominant 45,X,-Y karyotype in donor cells after allogeneic BMT. Cancer Genet Cytogenet 1996; 86: 1–7.

    Article  CAS  PubMed  Google Scholar 

  44. Lawler M, Locasciulli A, Longoni D, Schiro R, McCann SR . Leukemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anemia. Bone Marrow Transplant 2002; 29: 453–456.

    Article  CAS  PubMed  Google Scholar 

  45. Hambach L, Eder M, Dammann E, Battmer K, Stucki A, Heil G et al. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 2001; 28: 705–707.

    Article  CAS  PubMed  Google Scholar 

  46. Sala-Torra O, Hannna C, Loken MR, Flowers MED, Maris M, Ladne PA et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 511–517.

    Article  PubMed  Google Scholar 

  47. Au WY, Chan EC, Siu LLP, Lau TCM, Lie AKW, Ma SK et al. Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol 2002; 119: 777–780.

    Article  CAS  PubMed  Google Scholar 

  48. Komeno Y, Kanda Y, Kandabayashi K, Kawazu M, Goyama S, Takeshita M et al. Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol 2003; 72: 220–222.

    Article  PubMed  Google Scholar 

  49. Haltrich I, Müller J, Szabó J, Kovács G, Kóos R, Poros A et al. Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet 2003; 142: 124–128.

    Article  PubMed  Google Scholar 

  50. Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K . Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphobkastic leukemia: case report and review of the literature. Am J Hematol 2006; 81: 178–185.

    Article  PubMed  Google Scholar 

  51. Stein J, Zimmerman PA, Kochera M, Strandjord S, Golden W, Simon M et al. Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses. Blood 1989; 73: 2033–2040.

    CAS  PubMed  Google Scholar 

  52. Saito Y, Uzuka Y, Sakai N, Suzuki S, Toyota TA . Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Bone Marrow Transplant 2000; 25: 1209–1211.

    Article  CAS  PubMed  Google Scholar 

  53. Gopsca L, Barta A, Banyai A, Konya M, Pajor L, Földi J et al. Acute myeloid Leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 2002; 29: 449–452.

    Article  Google Scholar 

  54. Takahashi R, Shimazaki C, Inaba T, Nakagawa M, Yamaoka M . Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia. Jpn J Clin Hematol 2002; 43: 963–965.

    Google Scholar 

  55. Lang Z, Dinndorf P, Ladisch S, Bayever E, Reaman G . Chromosomal transformation in donor cells following allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 33: 1253–1256.

    Article  CAS  PubMed  Google Scholar 

  56. Daly AS, Reid SK, Lipton JH, Messner HA, Kiss TL, Chun K et al. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia. Leuk Res 2004; 28: 1107–1111.

    Article  PubMed  Google Scholar 

  57. Kraut L, Trebeljahr G, Thiele B, Frauser AA . Donor cell-derived myelodyaplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia. Bone Marrow Transplant 2005; 36: 737.

    Article  CAS  PubMed  Google Scholar 

  58. Pieroni F, Oliveira FM, Panepucci RA, Voltarelli JC, Simóes BP, Falcáo RP . Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia. Bone Marrow Transplant 2006; 37: 801–802.

    Article  CAS  PubMed  Google Scholar 

  59. Ataergin S, Arpaci F, Cetin T, Guran S, Yakicier C, Beyzadeoglu M et al. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia. Am J Hematol 2006; 81: 370–373.

    Article  PubMed  Google Scholar 

  60. Jacobs JFM, Brons PP, Simons A, Van der Reijden BA, Hoogerbrugge PM . Therapy related, donor-derived AML responding to a second allogeneic BMT. Bone Marrow Transplant 2007; 40: 499–500.

    Article  CAS  PubMed  Google Scholar 

  61. Igarashi N, Chou T, Hirose T, Imai Y, Ishiguro T, Nemoto K . Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma. Int J Hematol 2009; 90: 378–382.

    Article  PubMed  Google Scholar 

  62. Mouri F, Nomura N, Iwashige J, Yasuyama H, Kitamura N, Nakanishi T . Donor cell MDS and esophageal cancer following allogeneic BMT for MDS. Jpn J Clin Hematol 2009; 50: 1090 (abstr).

    Google Scholar 

  63. Wiseman DH, Das M, Poulton K, Liakopoulou E . Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestine. Am J Hematol 2011; 3: 315–318.

    Article  Google Scholar 

  64. Norkin M, Uberti JP, Schiffer CA, Karmanos BA . Very late recurrences of leukemia: why does leukemia awake after many years of dormancy? Leuk Res 2011; 35: 139–144.

    Article  PubMed  Google Scholar 

  65. Otero L, De Souza DC, Tavares RC, Gomes BE, Padilha TF, Bouzas LF et al. Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: report of a new case and review of the literature. Genet Mol Biol 2012; 35: 734–736.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Jiménez P, Alvarez JC, Garrido P, Lorente JA, Palacios J, Ruiz-Cabello F . Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemia. Int J Biomed Sci 2012; 8: 244–248.

    PubMed  PubMed Central  Google Scholar 

  67. Boyd CN, Ramberg RC, Thomas ED . The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res 1982; 6: 833–837.

    Article  CAS  PubMed  Google Scholar 

  68. Kliegman RM, Stanton BF, Schor NF, St Geme III JW, Behrman RE . The leukemias. In: Tubergen DG, Bleyer T, Ritchy AK, (eds). Nelson Textbook of Pediatrics 19th edn Elsevier Publishing LTD: Philadelphia, PA, USA, 2011 pp 1732–1739.

    Google Scholar 

  69. Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002; 99: 8242–8247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 2002; 99: 3801–3805.

    Article  CAS  PubMed  Google Scholar 

  71. Flynn CM, Kaufman DS . Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood 2007; 109: 2688–2692.

    CAS  PubMed  Google Scholar 

  72. Szabolcs P, Cairo MS . Unrelated umbilical cord blood transplantation and immune reconstitution. Semin Hematol 2010; 47: 22–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Holyoake TL, Nicolini FE, Eaves CJ . Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999; 27: 1418–1427.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Tokyo Women’s Medical University, Tokyo, Japan

    H Shiozaki, K Yoshinaga, T Kondo, Y Imai, M Shiseki, N Mori, M Teramura & T Motoji

Authors
  1. H Shiozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Yoshinaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Shiseki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Teramura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Motoji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Yoshinaga.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shiozaki, H., Yoshinaga, K., Kondo, T. et al. Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source. Bone Marrow Transplant 49, 102–109 (2014). https://doi.org/10.1038/bmt.2013.127

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.127

Keywords

This article is cited by

Search

Advanced search

Quick links